Publication: 124

Publication: 124

Thalidomide has limited single-agent activity in relapsed or refractory indolent non-Hodgkin lymphomas: a phase II trial of the Cancer and Leukemia Group B.

PubMed

DOI

Google Scholar

Citation:: Br J Haematol vol 140 (3) 313-9

Year:: 2008
Type:: Manuscript
Funding:: NCTN
Endpoint:: Primary
Analysis:: Primary
Data Sharing:: No-Data-Sharing
Status:: Presented/Published
Citation Status:: pub

Note:

Methodological:: No
Biospecimen:: No
SDC:: No
Book Volume:

Parents:: None
Children:: None

Program:: OGC
Primary Committee:: Lymphoma
Sec. Committees:

Pharmas:
Grants:

Corr. Author:
Authors:: Sonali M Smith David Grinblatt Jeffrey L Johnson Donna Niedzwiecki David Rizzieri Nancy L Bartlett Bruce D Cheson

Networks:

Study: CALGB-50002
Multiple Studies, or Legacy Studies in Alliance Study:
Phases:: 2

Keywords:: Adult, Aged, Aged, 80 and over, Disease-Free Survival, Drug Administration Schedule, Female, Humans, Immunosuppressive Agents, Lymphoma, Non-Hodgkin, Male, Middle Aged, Recurrence, Remission Induction, Thalidomide, Thromboembolism, Treatment Failure